Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 496 of 496 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/25/13
End: 06/19/14
Due: 06/19/15
Phase: N/A
Priority: Normal
Start: 01/13/21
End: 02/27/24
Due: 02/27/25
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
Phase: N/A
Priority: Normal
Start: 11/29/15
End: 05/30/16
Due: 05/30/17
Phase: N/A
Priority: Normal
Start: 05/31/10
End: -
Due: -
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 09/21/17
End: 11/20/18
Due: 11/20/19
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 03/05/09
End: 11/14/12
Due: 11/14/13
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 08/25/10
End: 03/18/11
Due: 03/18/12
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 03/09/20
End: 12/15/25
Due: 12/15/26
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 11/16/20
End: 11/14/22
Due: 11/14/23
Phase: N/A
Priority: Normal
Start: 02/17/15
End: 08/02/17
Due: 08/02/18
Phase: N/A
Priority: Normal
Start: 11/06/24
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 04/30/03
End: 10/31/04
Due: 10/31/05
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 06/30/12
Due: 06/30/13